Ontak and cardiomegaly Patient Reports February 13, 2012

Ontak Side Effects Report #5643730-6
Ontak side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma  and was treated with Ontak. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardiac arrest , cardiomegaly, dizziness , hepatic congestion, insomnia, oedema. Ontak dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.

Ontak Side Effects Report #5663755-4
Ontak side effect was reported by a Physician from UNITED STATES on Feb 28, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: asthenia, bradycardia, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation, malaise, nausea , pain . Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5675840-1
Ontak side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, back pain , blood glucose increased, cardio-respiratory arrest, cardiomegaly, musculoskeletal pain, nausea , overweight. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS; INTERMITTENT SINCE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5710514-X
Ontak side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, back pain , blood creatine phosphokinase increased, blood glucose increased, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.


Ontak Side Effects Report #5717053-0
Ontak side effect was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: abdominal hernia, arthralgia, asthenia, back pain , bradycardia, cardiac arrest , cardio-respiratory arrest, cardiomegaly, dyspnoea. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.